HLS Therapeutics Inc (HLTRF) Stock Price & News

All values in USD	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	14.17M	13.51M	15.20M	12.86M
Cost of goods sold	3.87M	3.81M	4.28M	4.19M
Cost of revenue	3.87M	3.81M	4.28M	4.19M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.13M	4.78M	5.21M	5.21M
Operating expense	11.08M	11.08M	10.68M	10.89M
Total operating expenses	14.95M	14.88M	14.96M	15.08M
Operating income	-778.00K	-1.37M	237.00K	-2.22M
Other non operating income	-31.00K	-534.00K	-517.00K	-87.00K
EBT including unusual items	-2.50M	-3.94M	-1.98M	-2.30M
EBT excluding unusual items	-2.50M	-3.94M	-1.98M	-2.30M
Income tax expense	242.00K	-17.00K	-647.00K	2.00K
Effective tax rate	-9.68%	0.43%	32.64%	-0.09%
Other operating expenses	-	-	-	-
Net income	-2.74M	-3.92M	-1.34M	-2.30M
Net profit margin	-19.34%	-29.00%	-8.79%	-17.86%
Earnings per share	-0.09	-0.12	-0.04	-0.07
Interest and investment income	33.00K	24.00K	18.00K	12.00K
Interest expense	-1.73M	-2.44M	-897.00K	-801.00K
Net interest expenses	-1.70M	-2.42M	-879.00K	-789.00K
Depreciation and amortization charges	5.48M	5.51M	5.46M	5.54M
EBITDA	4.70M	4.14M	5.18M	3.32M
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance